Literature DB >> 7608700

Immunoglobulin treatment in human and experimental epilepsy.

K Van Rijckevorsel, M Delire.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7608700      PMCID: PMC1073621          DOI: 10.1136/jnnp.59.1.105-b

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  3 in total

1.  Intravenous immunoglobulin: a single-blind trial in children with Lennox-Gastaut syndrome.

Authors:  N Illum; K Taudorf; C Heilmann; T Smith; K Wulff; B Mansa; P Platz
Journal:  Neuropediatrics       Date:  1990-05       Impact factor: 1.947

Review 2.  Immunoglobulin treatment in human and experimental epilepsy.

Authors:  B G van Engelen; W O Renier; C M Weemaes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

3.  Treatment of refractory epilepsy with intravenous immunoglobulins. Results of the first double-blind/dose finding clinical study.

Authors:  K van Rijckevorsel-Harmant; M Delire; W Schmitz-Moorman; H G Wieser
Journal:  Int J Clin Lab Res       Date:  1994
  3 in total
  1 in total

1.  Modulation of Immunity and the Inflammatory Response: A New Target for Treating Drug-resistant Epilepsy.

Authors:  Nian Yu; Hao Liu; Qing Di
Journal:  Curr Neuropharmacol       Date:  2013-01       Impact factor: 7.363

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.